2022-04-06 Ӣͬx~:3-Fluorobenzoylacetonitrile,98%;3-FLUOROBENZOYLACETONITRILE;JR-13683,3-(3-Fluorophenyl)-3-oxopropanenitrile,97%;Benzenepropanenitrile,3-fluoro--oxo- CAS̖(ho):21667-61-8 ʽ:C9H6FNO :163.15
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0090233 | 100mg |
1
|
ԃr(ji) |
Q-0090233 | 250mg |
1
|
ԃr(ji) |
Q-0090233 | 500mg |
1
|
ԃr(ji) |
Q-0090233 | 1g |
1
|
ԃr(ji) |
Q-0090233 | 5g |
1
|
ԃr(ji) |

3-Q
3-
Ӣ 3-(3-fluorophenyl)-3-oxopropanenitrile
Ąe 3-
ӢĄe Benzenepropanenitrile, 3-fluoro-β-oxo-
3-(3-Fluorphenyl)-3-oxopropanonitril
m-fluorobenzoylacetonitrile
3-Fluor-benzoylacetonitril
3-Fluorobenzoylacetonitrile
MFCD02260777
3-(3-Fluorophenyl)-3-oxopropanenitrile
3-W(xu)|(zh)
ܶ 1.2±0.1 g/cm3
c(din) 304.4±22.0 °C at 760 mmHg
c(din) 89-91ºC
ʽ C9H6FNO
163.148
Wc(din) 137.9±22.3 °C
**|(zh) 163.043335
PSA 40.86000
LogP 1.07
0.0±0.6 mmHg at 25°C
1.516
ȣ99%
;Hڿ
Yρ(li)С2022.04.06
ܰʾHڿw(sh)(yn)

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
10--2,3,4,6,7,11B--1H-O[2,1-A] Ӣ 10-chloro-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline ʽ C12H15ClN2 222.71400 |(zh) 222.09200 PSA 15.27000
-
Ӣ 1'-[(2-methylpropan-2-yl)oxycarbonyl]spiro[3,4-dihydrochromene-2,4'-piperidine]-4-carboxylic acid ʽ C19H25NO5 347.40600 |(zh) 347.17300
-
2022-04-02 Ӣͬx~:2-(4-bromophenyl)isothiazolidine1,1-dioxide;N-(4-BroMophenyl)-1,3-propanesultaM;2-(4-bromophenyl)-1,2-thiazolidine1,1-dioxide;Isothiazolidine,2-(4-bromophenyl)-,1,1-dioxide CAS̖(ho):71703-16-7 ʽ:C9H10BrNO2S :276.15
-
2022-04-02 Ӣͬx~:docosylamine;1-Docosanamine;Docosane-1-amine;Einecs237-982-7;Behenylamine;docosan-1-amine;1-aminodocosane CAS̖(ho):14130-06-4 ʽ:C22H47N :325.62